1. Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, et al. Osteoarthritis: new insights. Part 1: The disease and its risk factors. Ann Intern Med. 2000;133:635–646.
5. Pereira D, Peleteiro B, Araújo J, Branco J, Santos RA, Ramos E. The effect of osteoarthritis definition on prevalence and incidence estimates: Asystematic review. Osteoarthritis Cartilage. 2011;19:1270–1285.
6. Fernandes L, Hagen KB, Bijlsma JW, Andreassen O, Christensen P, Conaghan PG, et al. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann Rheum Dis. 2013;72:1125–1135.
8. Quandt SA, Chen H, Grzywacz JG, Bell RA, Lang W, Arcury TA. Use of complementary and alternative medicine by persons with arthritis: Results of the National Health Interview Survey. Arthritis Rheum. 2005;53:748–755.
10. Lee SI, Khang YH, Lee MS, Koo HJ, Kang WC, Hong CG. Complementary and alternative medicine use in Korea: Prevalence, pattern of use, and out-of-pocket expenditures. Korean J Prev Med. 1999;32:546–555. [in Korean].
11. Kim JI, Kang HS. Self-management of pain by folk remedies in patient with chronic arthritis. J Rheumatol Health. 1999;6:242–252.
12. Chandola A, Young Y, McAlister H, Axford JS. Use of complementary therapies by patients attending musculoskeletal clinics. J R Soc Med. 1999;92:13–16.
13. Boisset M, Fitzcharles MA. Alternative medicine use by rheumatology patients in a universal health care setting. J Rheumatol. 1994;21:148–152.
14. Vecchio PC. Attitudes to alternative medicine by rheumatology outpatient attenders. J Rheumatol. 1994;21:145–147.
15. Kim YR, Yoo TS, Park HK, Kim TH, Jun JB, Jung SS, et al. Complementary and alternative medicine use and its usefulness in patients with RA. J Korean Rheum Assoc. 2002;9:173–183. [in Korean].
16. Jung HC, Park HM, Lee SD. Nationwide study on the characteristics of patients visiting and using Korean medical facilities by sex. J Korean Med. 2014;35:75–87. [in Korean].
17. Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Rheumatol. 2020;72:220–233.
18. Witt C, Brinkhaus B, Jena S, Linde K, Streng A, Wagenpfeil S, et al. Acupuncture in patients with osteoarthritis of the knee: Arandomised trial. Lancet. 2005;366:136–143.
19. Scharf HP, Mansmann U, Streitberger K, Witte S, Krämer J, Maier C, et al. Acupuncture and knee osteoarthritis: Athree-armed randomized trial. Ann Intern Med. 2006;145:12–20.
20. Cao L, Zhang XL, Gao YS, Jiang Y. Needle acupuncture for osteoarthritis of the knee. A systematic review and updated meta-analysis. Saudi Med J. 2012;33:526–532.
21. Chen N, Wang J, Mucelli A, Zhang X, Wang C. Electro-Acupuncture is Beneficial for Knee Osteoarthritis: The Evidence from Meta-Analysis of Randomized Controlled Trials. Am J Chin Med. 2017;45:965–985.
22. Jia J, Mao GI, Hu SH, Dong XC. Acupuncture combined with functional exercise for the elder patients with knee osteoarthritis. Chin J Tissue Eng Res. 2005;9:18–19.
23. Chang SH, Song YK, Nah SS. The clinical efficacy and safety of Gumiganghwal-tang in knee osteoarthritis: Aphase II randomized double blind placebo controlled study. Evid Based Complement Alternat Med. 2018;2018:3165125.
25. Zakeri Z, Izadi S, Bari Z, Soltani F, Narouie B, Ghasemi-Rad M. Evaluating the effects of ginger extract on knee pain, stiffness, and difficulty in patients with knee osteoarthritis. J Med Plant Res. 2011;5:3375–3379.
26. Lee JH. Essential Formulae in Oriental Medicine with Illustrations. 1st revision ed.Wonju (Korea): Uibang Publications. 2007:97.
27. Ahn BS, Kim SK, Kim HN, Lee JH, Lee JH, Hwang DS, et al. Gyejigachulbu-Tang relieves oxaliplatin-induced neuropathic cold and mechanical hypersensitivity in rats via the suppression of spinal glial activation. Evid Based Complement Alternat Med. 2014;2014:436482.
28. Schröder S, Beckmann K, Franconi G, Meyer-Hamme G, Friedemann T, Greten HJ, et al. Can medical herbs stimulate regeneration or neuroprotection and treat neuropathic pain in chemotherapy-induced peripheral neuropathy? Evid Based Complement Alternat Med. 2013;2013:423713.
30. Nakanishi M, Arimitsu J, Kageyama M, Otsuka S, Inoue T, Nishida S, et al. Efficacy of traditional Japanese herbal medicines - Keishikajutsubuto (TJ-18) and Bushi-matsu (TJ-3022) - against postherpetic neuralgia aggravated by self-reported cold stimulation: Acase series. J Altern Complement Med. 2012;18:686–692.
31. Satoh K, Takano S, Kobayashi T. Keishikajutsubuto (Guizhi-shu-fu-tang) treatment for refractory accumulation of synovial fluid in a patient with pustulotic arthro-osteitis. Fukushima J Med Sci. 2007;53:33–38.
32. Sul JU, Kim MK, Leem J, Jo HG, Yoon SH, Kim J, et al. Efficacy and safety of gyejigachulbutang (Gui-Zhi-Jia-Shu-Fu-Tang, Keishikajutsubuto, TJ-18) for knee pain in patients with degenerative knee osteoarthritis: Arandomized, placebo-controlled, patient and assessor blinded clinical trial. Trials. 2019;20:140.
33. American college of rheumatology subcommittee on osteoarthritis guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum. 2000;43:1905–1915.
34. Berman BM, Lao L, Langenberg P, Lee WL, Gilpin AM, Hochberg MC. Effectiveness of acupuncture as adjunctive therapy in osteoarthritis of the knee: Arandomized, controlled trial. Ann Intern Med. 2004;141:901–910.
35. Carlsson AM. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain. 1983;16:87–101.
36. Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149–158.
37. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: Ahealth status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833–1840.
38. Bae SC, Lee HS, Yun HR, Kim TH, Yoo DH, Kim SY. Cross-cultural adaptation and validation of Korean Western Ontario and McMaster Universities (WOMAC) and Lequesne osteoarthritis indices for clinical research. Osteoarthritis Cartilage. 2001;9:746–750.
39. Rothman M, Vallow S, Damaraju CV, Hewitt DJ. Using the patient global assessment of the method of pain control to assess new analgesic modalities in clinical trials. Curr Med Res Opin. 2009;25:1433–1443.
41. Kwon OS, Kim JE, Lee JW, Seo CW, Han HY, Hong SH. Analytic study of diagnostic validity by the measure of cold-heat anddeficiency-excess for oriental medical examination. J Physiol Pathol Korean Med. 2009;23:180–185. [in Korean].
42. Park YG, Ha CW, Han CD, Bin SI, Kim HC, Jung YB, et al. A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5, dried extracts of six herbs, for the treatment of osteoarthritis of knee joint. J Ethnopharmacol. 2013;149:816–824.
43. Yoh SB, Sul JU, Shin MS. Research trends on the treatment of knee osteoarthritis in Korean Medicine. Korean J Acupunct. 2011;28:139–155. [in Korean].
44. Kimura M, Kimura I, Muroi M, Yoshizaki M, Hikino H. Pharmacological evidence for an interaction between constituents (blend effect) of the Japanese-Sino medicine “Keishi-ka-zyutubu-tō” in neuromuscular blockade in diabetic mice. Phytother Res. 1987;1:107–113.
45. Yamada T, Kan H, Matsumoto S, Koizumi M, Sasaki J, Tani A, et al. Reduction in oxaliplatin-related neurotoxicity by the administration of Keishikajutsubuto (TJ-18) and powdered processed aconite root. Gan To Kagaku Ryoho. 2012;39:1687–1691. [in Japanese].
48. Atsumi T, Iwashita A, Ohtsuka I, Kakiuchi N, Sasaki Y, Mikage M, et al. Effects of Atractylodis Lanceae Rhizoma on inflammatory mediator production from the RAW264 macrophage cell line. J Trad Med. 2013;30:124–131.
49. Bose S, Kim H. Evaluation of in vitro anti-inflammatory activities and protective effect of fermented preparations of Rhizoma Atractylodis Macrocephalae on intestinal barrier function against lipopolysaccharide insult. Evid Based Complement Alternat Med. 2013;2013:363076.
50. Lee KO, Kuk YB, Yun YG. Effects of Jakyakgamchotang extract on the analgesic effect in mice. Herb Formula Sci. 2003;11:161–170.
51. Shin YS, Lee SI. A review study of researches on Jakyakgamcho-tang. Herb Formula Sci. 2017;25:271–302.
52. Myung NY. The improving effect of Zizyphus Jujube on dextran sulfate sodium-induced colitis in mice. Korea J Herbology. 2015;30:35–40. [in Korean].
53. Toriizuka M. The pharmacological action of kampo herbal prescription - Keishi-ka-jutsubu-to. Kampo Med. 1997;21:184–189.
54. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis. 1967;20:637–648.
55. Macpherson H. Pragmatic clinical trials. Complement Ther Med. 2004;12:136–140.
57. Song YJ, Ha CW. The use of COX-2 selective nonsteroidal anti-inflammatory drugs for the treatment of osteoarthritis. J Korean Knee Soc. 2009;21:84–92. [in Korean].